Yifei Xing

1.6k total citations
65 papers, 1.1k citations indexed

About

Yifei Xing is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yifei Xing has authored 65 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 21 papers in Cancer Research and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yifei Xing's work include Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (11 papers) and Prostate Cancer Treatment and Research (10 papers). Yifei Xing is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (11 papers) and Prostate Cancer Treatment and Research (10 papers). Yifei Xing collaborates with scholars based in China, Burundi and Japan. Yifei Xing's co-authors include Yarong Song, Yajun Xiao, Liang Chen, Lulin Cheng, Xuechao Li, Yunxue Li, Xuexiang Li, Ying Yu, Xuechao Li and Fang Lv and has published in prestigious journals such as Environmental Science & Technology, Oncogene and Chemical Engineering Journal.

In The Last Decade

Yifei Xing

61 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yifei Xing China 20 693 415 231 168 89 65 1.1k
Sungmin Lee South Korea 17 639 0.9× 365 0.9× 149 0.6× 259 1.5× 57 0.6× 29 1.1k
Yulin Sun China 20 649 0.9× 375 0.9× 163 0.7× 231 1.4× 64 0.7× 56 1.0k
Ronald C. Hendrickson United States 15 919 1.3× 265 0.6× 190 0.8× 280 1.7× 164 1.8× 17 1.4k
Yanyan Shen China 21 824 1.2× 293 0.7× 138 0.6× 219 1.3× 82 0.9× 63 1.2k
Hengyu Chen China 19 646 0.9× 453 1.1× 133 0.6× 165 1.0× 78 0.9× 46 1.1k
Soichiro Ikeda Japan 13 660 1.0× 214 0.5× 322 1.4× 187 1.1× 54 0.6× 27 1.1k
Ye Song China 18 776 1.1× 507 1.2× 168 0.7× 186 1.1× 44 0.5× 44 1.1k
Jérôme Durivault France 17 977 1.4× 638 1.5× 246 1.1× 297 1.8× 65 0.7× 35 1.4k
Tiefeng Jin China 24 900 1.3× 318 0.8× 135 0.6× 275 1.6× 70 0.8× 65 1.3k
Gabriel Leprivier Germany 18 1.2k 1.7× 524 1.3× 297 1.3× 208 1.2× 111 1.2× 35 1.5k

Countries citing papers authored by Yifei Xing

Since Specialization
Citations

This map shows the geographic impact of Yifei Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifei Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifei Xing more than expected).

Fields of papers citing papers by Yifei Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifei Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifei Xing. The network helps show where Yifei Xing may publish in the future.

Co-authorship network of co-authors of Yifei Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Yifei Xing. A scholar is included among the top collaborators of Yifei Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifei Xing. Yifei Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jinyu, Chun‐Yu Liu, Haoran Li, et al.. (2025). TTK promotes mitophagy by regulating ULK1 phosphorylation and pre-mRNA splicing to inhibit mitochondrial apoptosis in bladder cancer. Cell Death and Differentiation. 32(9). 1691–1706.
2.
Li, Haoran, Kang Chen, Lulin Cheng, et al.. (2025). FAM111B enhances glycolysis and promotes metastasis of prostate cancer by upregulating LDHA. Neoplasia. 69. 101227–101227.
3.
Liu, Chunyu, Liang Chen, Lulin Cheng, et al.. (2024). Protein phosphatase 1 regulatory subunit 15 A promotes translation initiation and induces G2M phase arrest during cuproptosis in cancers. Cell Death and Disease. 15(2). 149–149. 4 indexed citations
4.
Xing, Yifei, et al.. (2024). Aggravating effect: ESG performance and reputational penalty. Finance research letters. 72. 106515–106515. 3 indexed citations
5.
Chen, Liang, Wei Dong, Chenlu Yang, et al.. (2023). PABPN1 regulates mRNA alternative polyadenylation to inhibit bladder cancer progression. Cell & Bioscience. 13(1). 45–45. 8 indexed citations
6.
Cheng, Lulin, Bing Liu, Liang Chen, et al.. (2023). SGK2 promotes prostate cancer metastasis by inhibiting ferroptosis via upregulating GPX4. Cell Death and Disease. 14(1). 74–74. 41 indexed citations
7.
8.
Chen, Liang, Yarong Song, Teng Hou, et al.. (2022). Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism. Journal of Experimental & Clinical Cancer Research. 41(1). 194–194. 36 indexed citations
9.
Yu, Ying, Bing Liu, Xuexiang Li, et al.. (2022). ATF4/CEMIP/PKCα promotes anoikis resistance by enhancing protective autophagy in prostate cancer cells. Cell Death and Disease. 13(1). 46–46. 53 indexed citations
10.
Lu, Dingheng, Tianbao Yang, Chenghan Li, et al.. (2022). A pH-Dependent rhodamine fluorophore with antiproliferative activity of bladder cancer in Vitro/Vivo and apoptosis mechanism. European Journal of Medicinal Chemistry. 236. 114293–114293. 6 indexed citations
11.
12.
Zhang, Pu, Zijian Liu, Decai Wang, et al.. (2021). Scoring System Based on RNA Modification Writer-Related Genes to Predict Overall Survival and Therapeutic Response in Bladder Cancer. Frontiers in Immunology. 12. 724541–724541. 4 indexed citations
13.
Chen, Zhaohui, Likun Yang, Liang Chen, et al.. (2020). miR‐190b promotes tumor growth and metastasis via suppressing NLRC3 in bladder carcinoma. The FASEB Journal. 34(3). 4072–4084. 13 indexed citations
14.
Zhang, Peng, Xuechao Li, Yarong Song, et al.. (2016). Tyrosine receptor kinase B silencing inhibits anoikis-resistance and improves anticancer efficiency of sorafenib in human renal cancer cells. International Journal of Oncology. 48(4). 1417–1425. 25 indexed citations
15.
Xiao, Yajun, et al.. (2014). Adrenal Teratoma:a case report and literature review. 34(3). 369–371. 3 indexed citations
16.
Du, Yuefeng, Ying Shi, Yifei Xing, & Fuqing Zeng. (2008). Establishment of CXCR4-small interfering RNA retrovirus vector driven by human prostate-specific antigen promoter and its biological effects on prostate cancer in vitro and in vivo. Journal of Cancer Research and Clinical Oncology. 134(11). 1255–1264. 8 indexed citations
17.
Xing, Yifei, et al.. (2007). [Establishment of RNA interfering retrovirus vector targeting CXCR4 gene driven by human prostate-specific antigen promoter and its biological effects on prostate cancer cells].. PubMed. 29(7). 489–94. 1 indexed citations
18.
Xing, Yifei, Yajun Xiao, Fuqing Zeng, et al.. (2007). Altered expression of connexin-43 and impaired capacity of gap junctional intercellular communication in prostate cancer cells. Journal of Huazhong University of Science and Technology [Medical Sciences]. 27(3). 291–294. 11 indexed citations
19.
Xing, Yifei. (2002). The killing and bystander effect of HSV TK/GCV approach on prostate cancer cells. 1 indexed citations
20.
Xing, Yifei, Yajun Xiao, Fuqing Zeng, et al.. (2002). [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].. PubMed. 82(21). 1484–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sungmin Lee Breakdown of academic impact, for papers by Yulin Sun Breakdown of academic impact, for papers by Ronald C. Hendrickson Breakdown of academic impact, for papers by Yanyan Shen Breakdown of academic impact, for papers by Hengyu Chen Breakdown of academic impact, for papers by Soichiro Ikeda Breakdown of academic impact, for papers by Ye Song Breakdown of academic impact, for papers by Jérôme Durivault Breakdown of academic impact, for papers by Tiefeng Jin Breakdown of academic impact, for papers by Gabriel Leprivier
Rankless by CCL
2026